Skip to content
Open access · CC-BY via OpenAlex

Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes

Michail Michailidis, Despina Μoraitou, Despina Α. Tata, Kallirhoe Kalinderi, Theodora Papamitsou, Vasileios T. Papaliagkas

International Journal of Molecular Sciences · 2022 · ▲ 327 citations

Abstract

Globally, the incidence of type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) epidemics is increasing rapidly and has huge financial and emotional costs. The purpose of the current review article is to discuss the shared pathophysiological connections between AD and T2DM. Research findings are presented to underline the vital role that insulin plays in the brain's neurotransmitters, homeostasis of energy, as well as memory capacity. The findings of this review indicate the existence of a mechanistic interplay between AD pathogenesis with T2DM and, especially, disrupted insulin signaling. AD and T2DM are interlinked with insulin resistance, neuroinflammation, oxidative stress, advanced glycosylation end products (AGEs), mitochondrial dysfunction(definition) and metabolic syndrome. Beta-amyloid, tau protein and amylin can accumulate in T2DM and AD brains. Given that the T2DM patients are not routinely evaluated in terms of their cognitive status, they are rarely treated for cognitive impairment. Similarly, AD patients are not routinely evaluated for high levels of insulin or for T2DM. Studies suggesting AD as a metabolic disease caused by insulin resistance in the brain also offer strong support for the hypothesis that AD is a type 3 diabetes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms23052687
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Michailidis, M., Μoraitou, D., Tata, D.�., Kalinderi, K., Papamitsou, T., &amp; Papaliagkas, V.T. (2022). Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms23052687
Vancouver
Michailidis M, Μoraitou D, Tata D�, Kalinderi K, Papamitsou T, Papaliagkas VT. Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms23052687.
BibTeX
@article{michail2022Alzhei, title = {Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes}, author = {Michail Michailidis and Despina Μoraitou and Despina Α. Tata and Kallirhoe Kalinderi and Theodora Papamitsou and Vasileios T. Papaliagkas}, journal = {International Journal of Molecular Sciences}, year = {2022}, doi = {10.3390/ijms23052687}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings